Prelude Capital Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Prelude Capital Management’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,948	Closed	-$37K	–	1267
2020 Q3	$37K	Sell	1,948 -241	-11%	-$4.85K	﹤0.01%	1197
2020 Q2	$49K	Buy	+2,189	New	+$40.1K	﹤0.01%	1164
2019 Q4	–	Sell	-2,435	Closed	-$48K	–	1891
2019 Q3	$48K	Sell	2,435 -3,500	-59%	-$72.9K	﹤0.01%	1168
2019 Q2	$125K	Sell	5,935 -3,000	-34%	-$62.7K	0.01%	875
2019 Q1	$183K	Buy	8,935 +5,388	+152%	+$121K	0.01%	740
2018 Q4	$71K	Buy	+3,547	New	+$69.9K	﹤0.01%	1027
2018 Q2	–	Sell	-1,750	Closed	-$33K	–	1645
2018 Q1	$33K	Buy	+1,750	New	+$32.9K	﹤0.01%	1185
2017 Q2	–	Sell	-2,326	Closed	-$34K	–	1582
2017 Q1	$34K	Sell	2,326 -7,943	-77%	-$125K	﹤0.01%	1149
2016 Q4	$189K	Sell	10,269 -17,449	-63%	-$339K	0.02%	602
2016 Q3	$526K	Buy	27,718 +6,640	+32%	+$121K	0.06%	302
2016 Q2	$340K	Buy	21,078 +2,000	+10%	+$28.2K	0.05%	359
2016 Q1	$229K	Sell	19,078 -7,400	-28%	-$87.2K	0.03%	508
2015 Q4	$377K	Buy	26,478 +5,400	+26%	+$71.3K	0.06%	348
2015 Q3	$246K	Buy	+21,078	New	+$316K	0.04%	499

Other funds holding AMPH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Prelude Capital Management's AMPH Position: Q4 2020 in Review

Prelude Capital Management sold out of Amphastar Pharmaceuticals (AMPH) in Q4 2020, closing a stake of 1,948 shares — an estimated $37K sold.

Prelude Capital Management first reported a position in AMPH in Q3 2015 and held it in 14 quarters. The position peaked at $526K in Q3 2016. 129 funds tracked by Wall St. Rank hold AMPH as of Q4 2020.

Prelude Capital Management reported no remaining Amphastar Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
Prelude Capital Management sold 1,948 Amphastar Pharmaceuticals shares in Q4 2020, an estimated $37K.
Prelude Capital Management first reported a position in Amphastar Pharmaceuticals in Q3 2015 and held it in 14 quarters.
Prelude Capital Management's Amphastar Pharmaceuticals position peaked at $526K in Q3 2016.
129 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q4 2020.

Based on Prelude Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.